Radiotherapy plays an important role in curative and palliative cancer treatment. As a novel radiation delivery technique, stereotactic radiotherapy utilizes three-dimensional-conformal treatment planning, high-precision beam delivery technology, and patient specific position verification to target tumors, often in one to five high-dose fractions. Currently, there is no consensus about best stereotactic radiotherapy practices in veterinary radiotherapy. The objective of this study was to document the breadth of perspectives, techniques, and applications of stereotactic radiotherapy in veterinary medicine. We conducted an online survey of American College of Veterinary Radiology members specializing in radiation oncology to assess how, when, and why stereotactic radiotherapy is being used. Both stereotactic radiotherapy users and nonusers completed the survey. The overall response and survey completion rates were 54% (67/123) and 87% (58/67), respectively. Overall, 55% of respondents reported providing stereotactic radiotherapy at their facility, with a median of 4.5 canine cases and one feline case per month. Delivery methods included C-arm linear accelerator with multi-leaf collimator, helical tomotherapy, and CyberKnife.
INTRODUCTION
Radiation therapy has played a significant role in the treatment of cancer in veterinary patients. The various technologies utilized to deliver radiation therapy have evolved over time, beginning with noncomputerized manual radiation therapy to newer methods such as intensitymodulated radiation therapy (IMRT), image-guided radiotherapy, and the focus of this study, stereotactic radiation therapy. Stereotactic radiotherapy is a novel method of radiation delivery that integrates three-dimensional imaging, advanced computerized treatment planning, and specialized beam delivery technologies so that conformal hypofractionated radiation protocols can be delivered in a relatively short period of time, while sparing normal tissue. The goal of delivering large radiation doses to the tumor is to achieve a greater antitumor biological effect than can be achieved through conventional fractionation. [1] [2] [3] Another advantage of stereotactic radiotherapy is the convenience of completing radiation therapy in a limited number of fractions usually within 1 week, compared to conventional approaches that often involve daily treatments over multiple weeks.
In 2001, a study reported that 80% of veterinary radiation plans were manually calculated, while 20% were computer planned. 4 Since that time, there has been rapid advancement in the technology used to plan and deliver radiation treatments. A more recent survey of veterinary radiation practices performed in 2010 indicated that 92% of facilities used 3D computerized planning with a median of 50% of plans being computer generated (range: 20-100%). 5 In the 2010 survey, 28% of facilities indicated the capacity to deliver stereotactic radiotherapy but details of the planning, quality assurance, and treatment techniques utilized were not reported. 5 Over the past few years, a number of manuscripts have been published suggesting a more widespread adoption of stereotactic radiotherapy. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] There is limited knowledge regarding current stereotactic radiotherapy practices in veterinary medicine. To continue advancing stereotactic radiotherapy in veterinary oncology, a better understanding of how it is being used is needed. Differences in practices among clinicians and institutions represent potential hurdles to the widespread implementation of stereotactic radiotherapy in clinical practice, particularly with respect to interpretation and repeatability of reported outcomes. To address this need, an online survey of American College of Veterinary Radiology members specializing in radiation oncology was conducted to assess how, when, and why stereotactic radiotherapy is being used. We hypothesized that there is wide variation in stereotactic radiotherapy usage among veterinary radiation oncology clinicians. We aimed to characterize the variation in terms of equipment types, treatment planning techniques, treatment indications, fractionation schemes, and quality assurance methods.
MATERIALS AND METHODS
Survey questions were developed to assess stereotactic radiotherapy usage in veterinary medicine. Questions were distributed to participants via online survey using Qualtrics software (Qualtrics R , Provo, Utah). The survey was available from August 16, 2016 to October 22, 2016. Prior to distribution, six clinicians involved in stereotactic radiotherapy planning and delivery at our facility completed the survey with the aim of providing feedback. The survey design consisted of initial questions regarding demographics and general radiation therapy equipment questions that all participants were asked. All participants were asked to provide their definition of the term 'stereotactic radiotherapy' . Skip logic was then used to direct respondents to specific questions based on whether or not they use stereotactic radiotherapy techniques in their practice. This allowed participants to be designated as stereotactic radiotherapy users and nonstereotactic radiotherapy users. Nonstereotactic radiotherapy users were asked a total of 12 questions, while stereotactic radiotherapy users were asked a total of 36 questions. 
Selection and description of subjects
Participants for the online survey were identified using the American The definitions of stereotactic radiotherapy provided in free text format were analyzed based on frequency of equivalent or near equivalent key terms, and then grouped according to the defining terms used in the American Association of Physicists in Medicine Task Group 101 report 22 The key terms used from Task Group 101 included:
Data recording and analysis
high target dose, accurate radiation delivery, conformity, and dose heterogeneity.
RESULTS
The overall response rate for the survey was 54% (67/123) and the completion rate was 87% (58/67). 
Characteristics of survey respondents

Stereotactic radiation therapy use
Of 66 respondents providing information on stereotactic radiotherapy usage, 36 (55%) reported performing stereotactic radiotherapy at their facility ("stereotactic radiotherapy users"), 22 
Notes. The percentages of SRT users given in parenthesis is based on 36 respondents while the percentages of non-SRT users given in parenthesis is based on 29 respondents for geographic location and board certification and 30 respondents for practice type. SRT, stereotactic radiation therapy.
plans for delivery at a distant practice. Table 2 shows the study population characteristics for stereotactic radiotherapy and nonstereotactic radiotherapy users. Stereotactic radiotherapy use was more prevalent in academia (including combined academic/private facilities) than in private practice-only facilities (22/32, 69% vs. 14/34, 41%, P = 0.03).
The median number of years of stereotactic radiotherapy experience reported by 31 respondents was 4 (interquartile range: 2-5.5). The median number of canine patients treated using stereotactic radiotherapy was 4.5 canine patients per month (range: 1-20 cases/month) and one feline patient per month (Range: 0-8 cases/month). Other species treated by stereotactic radiotherapy included rabbits, ferrets, reptiles, and goats.
Personnel involved in radiotherapy delivery
For stereotactic radiotherapy and nonstereotactic radiotherapy users, participants were asked which of the following personnel categories are actively involved radiotherapy delivery: radiation oncologist, radiologist, doctor of veterinary medicine (nonboarded and nonresident), medical physicist, anesthesiologist, resident (radiation oncology, radiology, or anesthesia), human trained radiation therapist, veterinary technician, anesthesia certified technician, or other. Being actively involved in radiotherapy delivery was defined as being involved in radiation treatment planning, quality assurance and/or radiation delivery.
All stereotactic radiotherapy users (36/36) and 90% (26/29) of non-stereotactic radiotherapy users reported that a board-certified radiation oncologist was involved in radiotherapy delivery. All 
Defining stereotactic radiation therapy
To determine how clinicians characterize stereotactic radiotherapy in veterinary medicine, all participants (stereotactic radiotherapy and nonstereotactic radiotherapy users) were asked to define stereotactic
radiotherapy in an open-ended, free text survey question. Sixty-four respondents (96%) provided stereotactic radiotherapy definitions. Table 3 shows the terms or concepts used by the respondents, and Table 4 shows how these terms were grouped for analysis. Twenty-two respondents (34%) defined stereotactic radiotherapy in accordance with three of four major terms used by the American Association 
Stereotactic radiation therapy delivery systems, treatment techniques
The most common system used to deliver stereotactic radiotherapy 
TA B L E 4 Respondent stereotactic radiation therapy terms and concepts grouped according to american association of physicists in medicine definition
AAPM Defining Terms of SRT 22
Corresponding terms or concepts from 
Notes. The number of respondents using each of the AAMP's four criteria for defining SRT was analyzed. SRT, stereotactic radiation therapy; AAPM, American Association of Physicists in Medicine. 
Stereotactic radiation therapy treatment planning
Stereotactic radiation therapy treatment protocols
Treatment protocols, including fraction number, dose in Gray (Gy) per fraction, and schedule provided by respondents for each tumor type are listed in Supporting Information 1. The treatment protocols for each tumor type were analyzed in terms of the mode for fraction number and dose per fraction ( Table 5 ). The range for fraction number was 1-5, with the exception of two respondents (2/30) who utilized up to 20 fractions for multiple tumor types. The maximum Gy per fraction reported was 25 Gy, which was used by one respondent for appendicular bone tumors, and by another respondent for metastatic disease. No modification for respiratory motion was reported by 24% (7/29).
Patient immobilization and respiratory motion management
Patient position verification for stereotactic radiation therapy
The three most common patient imaging tools available on delivery systems used for stereotactic radiotherapy were megavoltage portal for an stereotactic radiotherapy plan to "pass" quality assurance testing: a minimum of 95% gamma for a 3-mm distance to agreement and a 3% absolute dose difference (7/29, 24%), a minimum of 95% gamma for a 2-mm distance to agreement, and a 2% absolute dose difference (9/29, 31%), a minimum of 95% gamma for a 1-mm distance to agreement and a 1% absolute dose difference (2/29, 7%). Thirty-one percent (9/29) did not know which benchmark was utilized but all of these respondents cited a medical physicist involved in plan quality assurance amongst other roles. Some respondents also indicated that their quality assurance acceptance criteria varied by case and selected more than one category.
Stereotactic radiation therapy user satisfaction assessment
Stereotactic radiotherapy users were asked to report overall satisfaction with five different radiation therapy techniques (Figure 4 ).
Overall, 62% (18/29) were "very satisfied" with stereotactic radiotherapy, 28% (8/29) were "somewhat satisfied", and 10% (3/29) were "neutral." Seventy-nine percent of respondents (19/24) were "very satisfied" with non-computerized (manual) radiotherapy, 82% (18/22) with three-dimensional conformational radiotherapy, 80% (20/25) with IMRT, and 89% (17/19) with image-guided radiation with on- 
Non-stereotactic radiation therapy user satisfaction with non-stereotactic radiation therapy techniques and plans to adopt stereotactic radiation therapy
Among respondents not currently performing stereotactic radiotherapy at their facility, satisfaction of alternative radiation therapy techniques was assessed. The radiation techniques with the highest number of "very satisfied" users were image-guided radiation with on-board CT or camera-guided imaging (2/3, 67%), threedimensional conformational radiotherapy (18/29, 62%) followed by non-computerized (manual) radiotherapy (15/28, 54%), and IMRT (4/9, 44%). The main reasons stereotactic radiotherapy was not adopted was a lack of necessary equipment (27/30, 90%), followed by a lack of data suggesting clinical benefit (7/30, 23%) and satisfaction 
Comments from non-stereotactic radiation therapy users
Some non-stereotactic radiotherapy users (six out of eight nonstereotactic radiotherapy users providing comments) expressed concern about the current use of stereotactic radiotherapy in veterinary medicine. Concerns included inappropriate selection of cases (based on tumor size, shape, and location), minimal published information on dose, fractionation, planning, radiobiological research into normal tissue tolerance or response, and high costs of utilizing the technology. Concerns regarding how stereotactic radiotherapy was presented to clients was also reported. In particular, it was stated that the term "curative intent" can be misleading to clients, that prognosis may be overstated and that client education regarding the potential for late side effects may be insufficient. Respondents also requested clearer definitions of stereotactic radiotherapy and improved transparency among the radiation oncology community in order to improve stereotactic radiotherapy research and the use of scientific data to guide clinical decisions.
Comments from stereotactic radiation therapy users
Similar to non-stereotactic radiotherapy users, stereotactic radiotherapy participants expressed a desire to further share data regarding stereotactic radiotherapy side effects, treatment outcomes, client satisfaction, and to carefully evaluate the advantages and disadvantages of providing this approach in order to provide better veterinary care.
Concern was also raised regarding misuse of stereotactic radiotherapy in less appropriate tumors/sites or for financial motivation rather than patient benefit. The need for stereotactic radiotherapy treatments to be supported by scientific data was also emphasized.
DISCUSSION
This is the first published survey of stereotactic radiotherapy use in veterinary medicine. It provides important information about current standards of practice and the perspectives of respondents who offer stereotactic radiotherapy. The overall survey response rate was 54%, similar to that of a 2010 survey of veterinary radiation facilities. 5 In our survey, 59% of respondents reported having IMRT capabilities and the majority (92%) of IMRT users perform stereotactic radiotherapy.
Overall, 55% (n = 36) of respondents identified as stereotactic radiotherapy users, suggesting an increase in stereotactic radiotherapy use compared to 2010 when 28% of facilities indicated the capacity to deliver stereotactic radiotherapy. Our survey was distributed to individuals, not facilities, so some facilities may be represented more than once. Stereotactic radiotherapy users had a median of 4 years of experience with stereotactic radiotherapy. They were more likely to work in academia than in private practice. The most common stereotactic radiotherapy delivery system was a C-arm linear accelerator equipped with a multileaf collimator (69%) using dynamic IMRT delivery. Helical tomotherapy and Cyberknife were also represented. Dogs were more commonly treated with stereotactic radiotherapy than cats, which likely reflects a higher canine caseload at most facilities.
The survey showed that within the veterinary community, there is a lack of consensus regarding how stereotactic radiotherapy should be defined. Stereotactic radiotherapy was most commonly character- Due to the complexity of stereotactic radiotherapy, collaborative studies as they were performed in the past, in which the description of treatment details are limited, will not be possible in the stereotactic radiotherapy era. Given the disparity in how stereotactic radiotherapy is applied in veterinary medicine, standardization, and description of every step from patient simulation to planning to machine quality assurance will be required for future collaborative stereotactic radiotherapy efforts. Pooling of data over prolonged time periods for retrospective studies or between institutions will also be problematic unless consensus guidelines are developed and followed.
Use of high dose, hypofractionated radiation in stereotactic radiotherapy makes it critical that case selection is appropriate. Nonpituitary intracranial tumors, pituitary tumors, and sinonasal tumors were the most common cancers treated using stereotactic radiotherapy in both dogs and cats. Given the low metastatic rate and well-defined nature of these tumors, they are seemingly reasonably suited to aggressive, highly conformal local therapy using stereotactic radiotherapy. While stereotactic radiotherapy was most frequently employed to treat gross disease, some respondents reported stereotactic radiotherapy treatment of microscopic disease after incomplete surgical resections or in the treatment of highly locally invasive tumor types such as injection site sarcoma and bladder tumors. Selecting stereotactic radiotherapy for treatment of microscopic disease is an emerging application in the human radiation oncology in the setting of CNS metastasis [26] [27] [28] [29] [30] but its utility in other microscopic settings is unclear.
Thorough and routine quality assurance of linear accelerators, treatment plans, and imaging systems is a necessary measure to minimize error and avoid accidental delivery of high dose radiation to critical organs. 31 All respondents (100%) delivering stereotactic radiotherapy in this study reported routine machine quality assurance and most (92%) reported routine on-board imaging quality assurance.
However, 17% of stereotactic radiotherapy respondents indicated that quality assurance is not always performed on stereotactic radiotherapy plans. Future collaborative studies of stereotactic radiotherapy in veterinary medicine will require standardization of case selection, contouring, machine, plan, and imaging quality assurance. 
